Compound Libraries

- A unique collection of 2450 anti-obesity compounds for high throughput and high content screening; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- 678 hypertension-related small molecules for high-throughput and high-content screening. - Targets include ACE, calcium channel, β-adrenergic receptor, HMG-CoA Reductase, etc. - Detailed instructions, compound structure, target information, activity description, etc. - NMR and HPLC analytical techniques to ensure high product purity and quality. - All compounds are available in stock.

- A unique collection of 240 calcium channel blockers and agonists for high throughput and high content screening; - Targeting different subtypes of calcium channels, such as L-type, T-type, N-type, and receptor-operated calcium channels. - Bioactivity and safety confirmed by pre-clinical research and clinical trials, some of which are FDA approved; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- A unique collection of 215 potassium channel blockers and agonists for high throughput and high content screening; - Targeting different subtypes of potassium channels, such as Kir1.1, Kir3.x, Kir6.x and Kv7.1, etc. - Bioactivity and safety confirmed by pre-clinical research and clinical trials, some of which are FDA approved; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- A unique collection of 170 sodium channel blockers and agonists for high throughput and high content screening; - Targeting different subtypes of sodium channels, such as Nav1.1, Nav1.2, Nav1.3, Nav1.4, etc. - Bioactivity and safety confirmed by pre-clinical research and clinical trials, some of which are FDA approved; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); - Structurally diverse, medicinally active, and cell permeable; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 89 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; - Targets include chemokines and their receptors, such as CCR, CXCR, CR, CX3CR, etc.; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- A unique collection of 524 neuroregeneration related compounds for high throughput and high content screening; - Targets several signaling pathways, such as Notch, MAPK, Wnt/β-catenin, mTOR, etc.; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - tructurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- More diversity: structurally diverse, medicinally active, and unique chemistry (strong IP potential); - More opportunity for further scaffold modification; - Attractively priced;